Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-16-041755
Filing Date
2016-11-10
Accepted
2016-11-10 16:10:10
Documents
7
Effectiveness Date
2016-11-10

Document Format Files

Seq Description Document Type Size
1 FORM S-8 atrn20161024b_s8.htm S-8 125285
2 EXHIBIT 4.1 ex4-1.htm EX-4.1 62669
3 EXHIBIT 4.2 ex4-2.htm EX-4.2 62681
4 EXHIBIT 4.3 ex4-3.htm EX-4.3 61846
5 EXHIBIT 5.1 ex5-1.htm EX-5.1 21698
6 EXHIBIT 23.1 ex23-1.htm EX-23.1 4950
7 EXHIBIT 23.2 ex23-2.htm EX-23.2 3406
  Complete submission text file 0001437749-16-041755.txt   343827
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-214554 | Film No.: 161988140
SIC: 7389 Services-Business Services, NEC